Compound, composition, cured product, optically anisotropic body, optical element, and light guide element

US2024182785A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024182785-A1
Application numberUS-202318394438-A
CountryUS
Kind codeA1
Filing dateDec 22, 2023
Priority dateJun 23, 2021
Publication dateJun 6, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

There is provided a compound represented by General Formula (I), a composition containing the compound represented by General Formula (I), a cured product, an optically anisotropic body, an optical element, and a light guide element. P 1 and P 2 each independently represent a hydrogen atom, —CN, —NCS, or a polymerizable group. Sp 1 and Sp 2 each independently represent a single bond or a specific linking group, Z 1 represents a specific linking group. However, two or more Z 1 's represent —C≡C—. Two Z's bonded to A 2 in —Z-A 2 -Z— in General Formula (I) do not represent —C≡C—. A 1 and A 2 each independently represent a specific group. A plurality of A 2 's may be the same or different from each other. n represents an integer of 3 to 7.

First claim

Opening claim text (preview).

What is claimed is: 1 . A compound represented by General Formula (I), in the General Formula (I), P 1 and P 2 each independently represent a hydrogen atom, —CN, —NCS, or a polymerizable group, Sp 1 and Sp 2 each independently represent a single bond or a divalent linking group, provided that Sp 1 and Sp 2 do not represent a divalent linking group having a group selected from the group consisting of an aromatic hydrocarbon ring group, an aromatic heterocyclic group, and an aliphatic hydrocarbon ring group, provided that both Sp 1 -P 1 and Sp 2 -P 2 are not methyl groups at the same time, Z 1 represents —O—, —S—, —CHRCHR—, —OCHR—, —CHRO—, —CO—, —SO—, —SO 2 —, —COO—, —OCO—, —CO—S—, —S—CO—, —O—CO—O—, —CO—NR—, —NR—CO—, —SCHR—, —CHRS—, —SO—CHR—, —CHR—SO—, —SO 2 —CHR—, —CHR—SO 2 —, —CF 2 O—, —OCF 2 —, —CF 2 S—, —SCF 2 —, —OCHRCHRO—, —SCHRCHRS—, —SO—CHRCHR—SO—, —SO 2 —CHRCHR—SO 2 —, —CH═CH—COO—, —CH═CH—OCO—, —COO—CH═CH—, —OCO—CH═CH—, —COO—CHRCHR—, —OCO—CHRCHR—, —CHRCHR—COO—, —CHRCHR—OCO—, —COO—CHR—, —OCO—CHR—, —CHR—COO—, —CHR—OCO—, —CR═CR—, —CR═N—, —N═CR—, —N═N—, —CR═N—N═CR—, —CF═CF—, or —C≡C—, R represents a hydrogen atom or an alkyl group having 1 to 10 carbon atoms, in a case where a plurality of R's are present, the plurality of R's may be the same or different from each other, a plurality of Z 1 's may be the same or different from each other, provided that two or more Z 1 's represent —C≡C—, two Z's bonded to A 2 in —Z 1 -A 2 -Z 1 — in the General Formula (I) do not represent —C≡C—, A 1 and A 2 each independently represent an aromatic hydrocarbon ring group, an aromatic heterocyclic group, or an aliphatic hydrocarbon ring group, which may have a substituent L, or represent a group obtained by linking two groups selected from the group consisting of an aromatic hydrocarbon ring group, an aromatic heterocyclic group, and an aliphatic hydrocarbon ring group, which may have a substituent L, provided that at least one of A 1 or A 2 linked to a triple bond represents a group represented by General Formula (A-1) or General Formula (A-2), and a plurality of A 2 's may be the same or different from each other, in the General Formulae (A-1) to (A-2), W 1 to W 14 each independently represent CR 1 or N, where R 1 represents a hydrogen atom or a substituent L, · represents a bonding position, the substituent L represents an alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 10 carbon atoms, an alkylamino group having 1 to 10 carbon atoms, an alkylthio group having 1 to 10 carbon atoms, an alkanoyl group having 1 to 10 carbon atoms, an alkanoyloxy group having 1 to 10 carbon atoms, an alkanoylamino group having 1 to 10 carbon atoms, an alkanoylthio group having 1 to 10 carbon atoms, an alkyloxycarbonyl group having 2 to 10 carbon atoms, an alkylaminocarbonyl group having 2 to 10 carbon atoms, an alkylthiocarbonyl group having 2 to 10 carbon atoms, a hydroxy group, an amino group, a mercapto group, a carboxy group, a sulfo group, an amide group, a cyano group, a nitro group, a halogen atom, an aldehyde group, or a polymerizable group, provided that in a case where the group has —CH 2 —, at least one —CH 2 — contained in the group may be replaced with —O—, —CO—, —CH═CH—, or —C≡C—, and in a case where the group has a hydrogen atom, at least one hydrogen atom contained in the group may be replaced with at least one selected from the group consisting of a fluorine atom and a polymerizable group, and n represents an integer of 3 to 7. 2 . The compound according to claim 1 , wherein n in the General Formula (I) represents 3. 3 . The compound according to claim 1 , wherein at least one of P 1 or P 2 in the General Formula (I) represents a polymerizable group. 4 . The compound according to claim 1 , wherein A 1 and A 2 in the General Formula (I) each independently represent the group represented by the General Formula (A-1), the group represented by the General Formula (A-2), or a group represented by General Formula (A-3), in the General Formula (A-3), W 15 to W 18 each independently represent CR 1 or N, where R 1 represents a hydrogen atom or the substituent L, and · represents a bonding position. 5 . The compound according to claim 1 , wherein at least one of A 1 or A 2 in the General Formula (I) has the substituent L. 6 . The compound according to claim 1 , wherein Z 1 in the General Formula (I) represents —CH 2 CH 2 —, —OCH 2 —, —CH 2 O—, or —C≡C—. 7 . The compound according to claim 1 , wherein in the General Formula (I), at least one of A 1 or A 2 linked to a triple bond represents the group represented by the General Formula (A-2). 8 . The compound according to claim 1 , wherein in the General Formula (I), Sp 1 represents a group represented by the General Formula (II), and Sp 2 represents a group represented by the General Formula (III), ·—S—W 21 —··  (II) ·—S—W 22 —··  (III) in the General Formulae (II) and (III), W 21 and W 22 each independently represent an alkylene group having 1 to 15 carbon atoms, where one or more methylene groups contained in the alkylene group may be each independently replaced with —O—, —S—, or —C(═O)—, ·'s each represent a bonding position to A 1 or A 2 , which is directly linked to Sp 1 or Sp 2 , and ··'s each represent a bonding position to P 1 or P 2 . 9 . The compound according to claim 1 , wherein the compound has liquid crystallinity. 10 . A composition comprising: the compound according to claim 1 . 11 . The composition according to claim 10 , further comprising: a polymerization initiator. 12 . The composition according to claim 10 , further comprising: a chiral agent. 13 . The composition according to claim 10 , wherein the composition has liquid crystallinity. 14 . The composition according to claim 10 , wherein the composition is used for forming an optically anisotropic layer. 15 . A cured product that is obtained by curing the composition according to claim 10 . 16 . An optically anisotropic body that is obtained by curing the composition according to claim 10 . 17 . An optical element comprising: an optically anisotropic layer formed from the composition according to claim 10 , wherein the optically anisotropic layer has an alignment pattern, and the alignment pattern is a liquid crystal alignment pattern in which an orientation of an optical axis, derived from a compound contained in the composition, continuously changes rotationally along at least one in-plane direction. 18 . A light guide element comprising: the optical element according to claim 17 ; and a light guide plate.

Assignees

Inventors

Classifications

  • the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate · CPC title

  • Pyridine condensed or bridged with another ring system, e.g. quinoline or acridine · CPC title

  • C09K19/322Primary

    Compounds containing a naphthalene ring or a completely or partially hydrogenated naphthalene ring · CPC title

  • linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters {or ethers} · CPC title

  • Ph-Ph-COO-Ph · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024182785A1 cover?
There is provided a compound represented by General Formula (I), a composition containing the compound represented by General Formula (I), a cured product, an optically anisotropic body, an optical element, and a light guide element. P 1 and P 2 each independently represent a hydrogen atom, —CN, —NCS, or a polymerizable group. Sp 1 and Sp 2 each independently represent a single bond or a sp…
Who is the assignee on this patent?
Fujifilm Corp
What technology area does this patent fall under?
Primary CPC classification C09K19/322. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jun 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).